Skip to content

Clinical trials

Phase 1/2 Carcinoma, Non-Small-Cell Lung trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1/2 Country / region: Germany Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20104
20111
20132
20141
20153
20163
20176
20193
20201
20212
20224
20234
20245
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting14
Active, not recruiting13
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Bristol-Myers Squibb3
Eli Lilly and Company3
Pierre Fabre Medicament3
AstraZeneca2
BioNTech SE2
EMD Serono Research & Development Institute, Inc.2
Hoffmann-La Roche2
Pfizer2
Revolution Medicines, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung48
Lung Neoplasms11
Neoplasms9
Colorectal Neoplasms8
Melanoma7
Colonic Neoplasms6
Bronchial Neoplasms5
Head and Neck Neoplasms5
Lung Diseases5
Neoplasm Metastasis5

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.